Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide Effects on Epicardial Fat in T2DM and CAD
NCT03260881Phase 4Completed
- Sponsor
- University of Miami
- Start
- Sep 2018
- Primary completion
- Sep 2024
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of liraglutide in type 2 diabetes mellitus (T2DM), coronary artery disease (CAD), sponsored by University of Miami. Started Sep 2018; status: completed.
02
Drugs
03
Conditions
type 2 diabetes mellitus (T2DM)coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT03260881.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03260881.